• Explore /
  • Poster
  • / Outcomes with chemotherapies and molecular characteristics of <i>HER2</i>-mutant lung cancers.

Outcomes with chemotherapies and molecular characteristics of HER2-mutant lung cancers.

Abstract Poster

Authors

null

Juliana Eng

Memorial Sloan Kettering Cancer Center, New York, NY

Juliana Eng , Bob T. Li , Meier Hsu , Jamie E. Chaft , Maria E. Arcila , Mark G. Kris

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Citation

J Clin Oncol 33, 2015 (suppl; abstr 8068)

DOI

10.1200/jco.2015.33.15_suppl.8068

Abstract #

8068

Poster Bd #

391

Abstract Disclosures

Similar Posters

First Author: Julien Mazières

First Author: Luis Manso

Poster

2022 ASCO Annual Meeting

Evaluation of stage IV pancreatic adenocarcinomas based on mutational profiling of tumors.

Evaluation of stage IV pancreatic adenocarcinomas based on mutational profiling of tumors.

First Author: Katherine E Poruk

First Author: Benjamin Besse